Serum levels of cystatin C in patients with malignancy

Clinical and Experimental Nephrology

Volumn 12, Issue 2, 2008, Pages 132-139

  Nakai, Keiko ^a   Kikuchi, Masayuki ^a   Fujimoto, Keiko ^a   Kaneko, Yoshito ^a   Omori, So ^a   Nakai, Kenji ^a   Suwabe, Akira ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

2 Microglobulin; Creatinine; CRP; Cystatin C; Malignancy

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CREATININE; CYSTATIN C;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BREAST CARCINOMA; COLON CANCER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; ESOPHAGUS CARCINOMA; FEMALE; GLOMERULUS FILTRATION RATE; HEAD AND NECK CANCER; HUMAN; KIDNEY FUNCTION; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEPHELOMETRY; PANCREAS CANCER; RECTUM CANCER; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 44549087682     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-008-0043-8     Document Type: Article

References (23)

1. Barrett AJ, Davis MF, Grubb A. The place of human γ-trace (cystatin C) amongst the cystein protease inhibitors. Biochem Biophys Res Commun. 1984;120:631-6.
2. Grubb A, Lofberg H. Human γ trace, a basic microprotein; amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA. 1982;79:3024-7.
3. Barret AJ, Fritz H, Grubb A, Isemura S, Jarvinen M, Katunuma N, et al. Nomenclature and classification of the protein homologous with chicken cystatin. Biochem J. 1986;236:312.
4. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (γ trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest. 1985;45:97-101.
5. Grubb A, Simonsen O, Sturtfelt G, Truedson L, Thysell H. Serum concentration of cystatin C, factor D and β2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand. 1985;218:499-503.
6. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AD, et al. Serum cystatin C measured by automated immunoassay; a more sensitive marker of change in GFR than serum creatinine. Kidney Int. 1995;47:312-8.
7. Hayashi T, Nitta K, Uchida K, Honda K, Kobayashi H, Kawashima A, et al. Clinical measurement of serum cystatin C as a marker of glomerular filtration rate. Clin Exp Nephrol. 2000;4:133-6.
8. Kos J, Štabuc B, Cimerman N, Brunner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem. 1998;44:2556-7.
9. Kos J, Štabuc B, Schweigen A, Krašovec M, Cimerman N, Kopitar-Jarala N, et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res. 1997;3:1815-22.
10. Sokol JP, Schiemann WP. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Mol Cancer Res. 2004;2:183-95.
11. Demirtas S, Akan O, Can M, Elmali E, Akan H. Cystatin C can be affected by nonrenal factors: a preliminary study on leukemia. Clin Biochem. 2006;39:115-8.
12. Knight EL, Verhave JC, Spiegelman D, Hillege HL, Zeew DD, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416-21.
13. Erlandsen EJ, Rander E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring nephelometer II System. Scand J Clin Lab Invest. 1999;59:1-8.
14. Ohara T, Nakai K, Orisaka M, Ito C, Saito K, Ito Y. A trial for establishing reference intervals of serum cystatin C in normal individuals. Jpn J Med Pharm Sci. 2000;43:835-44.
15. Page MK, Bukki J, Luppa P, Neumeier D. Clinical value of cystatin C determination. Clin Chim Acta. 2000;297:67-72.
16. Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A, et al. The role of cathepsin B and cystatin C in the mechanism of invasion by ovarian cancer. Gynecol Oncol. 2004;92:881-6.
17. Zore I, Krašovec M, Cimerman N, Kuhelj R, Werle B, Nielsen HJ, et al. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem. 2001;382:805-10.
18. Colle A, Tavera C, Prevot D, Leung-Tack J, Thomas Y, Manuel Y, et al. Cystatin C levels in sera of patients with human immunodeficiency virus infection. J Immnoassay. 1992;13:47-60.
19. Finney H, Williams AH, Price CP. Serum cystatin C in patients with myeloma. Clin Chem Acta. 2001;309:1-6.
20. Werle B, Sauckel K, Nathanson CM, Bjarnadottir M, Spiess E, Ebert W, et al. Cystatin C, E/M, and F in human pleural fluids of patients with neoplastic and inflammatory lung disorders. Biol Chem. 2003;384:281-7.
21. Reed CH. Diagnostic applications of cystatin C. Br J Biomed Sci. 2000;57:323-9.
22. Hansen T, Petrow PK, Gaumann A, Keyszer G, Brauer R, Kriegsmann J. Synovial giant cells in rheumatoid arthritis:expression of cystatin C, but not cathepsin B. Exp Toxicol Pathol. 2000;52:312-6.
23. Curhan G. Cystatin C:a marker of renal function or something more. Clin Chem. 2005;51:293-4.